Stoke Therapeutics (STOK) announced that Edward Kaye has decided to step down from his role as CEO effective as of March 19. To facilitate a ...
Waymo expands into South Bay, including San Jose & SFO, with permits for mapping. Learn how this pushes their autonomous taxi mission forward.
Goldman Sachs analyst expects positive updates from Vertex's first Investor Day as a public company on March 19, reiterates ...
Third annual All Nations Saint Patrick’s Day Parade, 10 a.m., downtown Rapid City. This year's parade supports Oglala Pet ...
Versar is a defense contracting and project management company headquartered in Springfield, Virginia. Its team specializes in engineering and construction, environmental services, professional ...
Vertex's Journavx, a new non-opioid pain drug, lands Tier 3 on Optum Rx formularies. Vertex reports $2.91 billion Q4 sales.
13d
Zacks Investment Research on MSNEditas Q4 Loss Wider Than Expected, Revenues Fall Y/Y, Stock DownEditas Medicine EDIT reported a loss of 55 cents per share in the fourth quarter of 2024, wider than the Zacks Consensus ...
Vertex Pharmaceuticals demonstrates resilience with robust CF franchise, new approvals, and diversification efforts. Read why ...
This decrease was primarily attributable to revenue recognized from the upfront payment under the Company’s license agreement with Vertex executed in December 2023. Research and development expenses ...
Jack Caporal, research director for The Motley Fool, analyzed all of Alphabet's references to AI in earnings calls from the end of December 2023 through ... products include Vertex AI Studio ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results